Patent ID: 11939594
Assignee: SEATTLE CHILDREN'S HOSPITAL
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 1:
2. The method of claim 1, wherein the polypeptide is selected from Factor VIII, Factor IX, serpin family G member 1 (SERPING1), serpin family A member 1 (SERPINA1), Factor H, Factor I, secretoglobin family 1A member 1 (SCGB1A1), apelin (APLN), interferon alpha (IFNα), B-cell activating factor (BAFF), a proliferation-inducing ligand (APRIL), interleukin-10 (IL-10), interleukin-6 (IL-6), a disintegrin and metallopeptidase with thrombospondin type 1 motif 13 (ADAMTS13), lipase A lysosomal acid lipase (LIPA), α-galactosidase A (GLA), or alkaline phosphatase biomineralization associated (ALPL).